The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Zwitterionic‐Coated “Stealth” Nanoparticles for Biomedical Applications: Recent Advances in Countering Biomolecular Corona Formation and Uptake by the Mononuclear Phagocyte System
Abstract
Nanoparticles represent highly promising platforms for the development of imaging and therapeutic agents, including those that can either be detected via more than one imaging technique (multi‐modal imaging agents) or used for both diagnosis and therapy (theranostics). A major obstacle to their medical application and translation to the clinic, however, is the fact that many accumulate in the liver and spleen as a result of opsonization and scavenging by the mononuclear phagocyte system. This focused review summarizes recent efforts to develop zwitterionic‐coatings to counter this issue and render nanoparticles more biocompatible. Such coatings have been found to greatly reduce the rate and/or extent of non‐specific adsorption of proteins and lipids to the nanoparticle surface, thereby inhibiting production of the “biomolecular corona” that is proposed to be a universal feature of nanoparticles within a biological environment. Additionally,in vivo studies have demonstrated that larger‐sized nanoparticles with a zwitterionic coating have extended circulatory lifetimes, while those with hydrodynamic diameters of ≤5 nm exhibit small‐molecule‐like pharmacokinetics, remaining sufficiently small to pass through the fenestrae and slit pores during glomerular filtration within the kidneys, and enabling efficient excretion via the urine. The larger particles represent ideal candidates for use as blood pool imaging agents, whilst the small ones provide a highly promising platform for the future development of theranostics with reduced side effect profiles and superior dose delivery and image contrast capabilities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer
Lukianova‐Hleb, E. Y., Oginsky, A. O., Samaniego, A. P., et al. (2011) · Theranostics · doi:10.7150/thno/v01p0003 · Cited by 73
RetractedMatsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles
Dubertret, B., Skourides, P., Norris, D. J., Noireaux, V., Brivanlou, A. H., & Libchaber, A. (2002) · Science · doi:10.1126/science.1077194 · Cited by 3,019
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors
Hardman, R. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8284 · Cited by 2,303
Chithrani, B. D., & Chan, W. C. W. (2007) · Nano Letters · doi:10.1021/nl070363y · Cited by 2,286
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Walkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
The emerging nanomedicine landscape
Wagner, V., Dullaart, A., Bock, A.-K., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,630
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration
De Jong, W. H., Hagens, W. I., Krystek, P., Burger, M. C., Sips, A. J. A. M., & Geertsma, R. E. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.037 · Cited by 1,615
Chemistry for peptide and protein PEGylation
Roberts, M. J., Bentley, M. D., & Harris, J. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00022-4 · Cited by 1,604
Pharmacokinetics and Biodistribution of Nanoparticles
Li, S.-D., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,568
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Sharifi, S., Behzadi, S., Laurent, S., Laird Forrest, M., Stroeve, P., & Mahmoudi, M. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15188f · Cited by 1,460
Iversen, T.-G., Skotland, T., & Sandvig, K. (2011) · Nano Today · doi:10.1016/j.nantod.2011.02.003 · Cited by 1,239
Mechanics of receptor-mediated endocytosis
Gao, H., Shi, W., & Freund, L. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503879102 · Cited by 1,217
What the Cell “Sees” in Bionanoscience
Walczyk, D., Bombelli, F. B., Monopoli, M. P., Lynch, I., & Dawson, K. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910675v · Cited by 1,184
Zwitterionic hydrogels implanted in mice resist the foreign-body reaction
Zhang, L., Cao, Z., Bai, T., Carr, L., Ella-Menye, J.-R., Irvin, C., Ratner, B. D., & Jiang, S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2580 · Cited by 1,035
Lesniak, A., Fenaroli, F., Monopoli, M. P., Åberg, C., Dawson, K. A., & Salvati, A. (2012) · ACS Nano · doi:10.1021/nn300223w · Cited by 1,020
Canton, I., & Battaglia, G. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15309b · Cited by 936
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb07033.x · Cited by 920
Nanomaterials: Applications in Cancer Imaging and Therapy
Barreto, J. A., O’Malley, W., Kubeil, M., Graham, B., Stephan, H., & Spiccia, L. (2011) · Advanced Materials · doi:10.1002/adma.201100140 · Cited by 907
Self-citationNanoparticles in cellular drug delivery
Faraji, A. H., & Wipf, P. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.02.043 · Cited by 903
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
Yu, M. K., Park, J., & Jon, S. (2012) · Theranostics · doi:10.7150/thno.3463 · Cited by 883
Nanoparticle Adhesion to the Cell Membrane and Its Effect on Nanoparticle Uptake Efficiency
Lesniak, A., Salvati, A., Santos-Martinez, M. J., Radomski, M. W., Dawson, K. A., & Åberg, C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja309812z · Cited by 852
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
Gref, R., Domb, A., Quellec, P., Blunk, T., Müller, R. H., Verbavatz, J. M., & Langer, R. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00026-4 · Cited by 820
The Evolution of the Protein Corona around Nanoparticles: A Test Study
Lundqvist, M., Stigler, J., Cedervall, T., Berggård, T., Flanagan, M. B., Lynch, I., Elia, G., & Dawson, K. (2011) · ACS Nano · doi:10.1021/nn202458g · Cited by 752
Parameters influencing the stealthiness of colloidal drug delivery systems
Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740
Assessment of the In Vivo Toxicity of Gold Nanoparticles
Chen, Y.-S., Hung, Y.-C., Liau, I., & Huang, G. S. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9334-6 · Cited by 695
Synergistically Integrated Nanoparticles as Multimodal Probes for Nanobiotechnology
Cheon, J., & Lee, J.-H. (2008) · Accounts of Chemical Research · doi:10.1021/ar800045c · Cited by 683
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00134-4 · Cited by 662
Ma, X., Wu, Y., Jin, S., Tian, Y., Zhang, X., Zhao, Y., Yu, L., & Liang, X.-J. (2011) · ACS Nano · doi:10.1021/nn202155y · Cited by 628
Reimer, P., & Balzer, T. (2003) · European Radiology · doi:10.1007/s00330-002-1721-7 · Cited by 614
In Vivo Biodistribution of Nanoparticles
Almeida, J. P. M., Chen, A. L., Foster, A., & Drezek, R. (2011) · Nanomedicine · doi:10.2217/nnm.11.79 · Cited by 583
Keefe, A. J., & Jiang, S. (2012) · Nature Chemistry · doi:10.1038/nchem.1213 · Cited by 576
Synthesis of Compact Multidentate Ligands to Prepare Stable Hydrophilic Quantum Dot Fluorophores
Uyeda, H. T., Medintz, I. L., Jaiswal, J. K., Simon, S. M., & Mattoussi, H. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044031w · Cited by 555
PEGylated Inorganic Nanoparticles
Karakoti, A. S., Das, S., Thevuthasan, S., & Seal, S. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201002969 · Cited by 551
Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
Moghimi, S. M., Hunter, A. C., & Andresen, T. L. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134623 · Cited by 545
Jin, H., Heller, D. A., Sharma, R., & Strano, M. S. (2009) · ACS Nano · doi:10.1021/nn800532m · Cited by 544
Recent advances in stealth coating of nanoparticle drug delivery systems
Amoozgar, Z., & Yeo, Y. (2012) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1157 · Cited by 528
Chemical Design of Biocompatible Iron Oxide Nanoparticles for Medical Applications
Ling, D., & Hyeon, T. (2013) · Small · doi:10.1002/smll.201202111 · Cited by 493
Drug Delivery and Transport to Solid Tumors
Jang, S. H., Wientjes, M. G., Lu, D., & Au, J. L.-S. (2003) · Pharmaceutical Research · doi:10.1023/a:1025785505977 · Cited by 483
Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery
Gullotti, E., & Yeo, Y. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900090z · Cited by 473
More Effective Nanomedicines through Particle Design
Wang, J., Byrne, J. D., Napier, M. E., & DeSimone, J. M. (2011) · Small · doi:10.1002/smll.201100442 · Cited by 466
Liu, D., Mori, A., & Huang, L. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90136-a · Cited by 463
FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease
Lu, M., Cohen, M. H., Rieves, D., & Pazdur, R. (2010) · American Journal of Hematology · doi:10.1002/ajh.21656 · Cited by 443
Fang, C., Shi, B., Pei, Y.-Y., Hong, M.-H., Wu, J., & Chen, H.-Z. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.002 · Cited by 424
Compact Cysteine-Coated CdSe(ZnCdS) Quantum Dots for in Vivo Applications
Liu, W., Choi, H. S., Zimmer, J. P., Tanaka, E., Frangioni, J. V., & Bawendi, M. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073790m · Cited by 415
Designing the nanoparticle–biomolecule interface for “targeting and therapeutic delivery”
Mahon, E., Salvati, A., Baldelli Bombelli, F., Lynch, I., & Dawson, K. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.009 · Cited by 385
Surface engineering of inorganic nanoparticles for imaging and therapy
Nam, J., Won, N., Bang, J., Jin, H., Park, J., Jung, S., Jung, S., Park, Y., & Kim, S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.015 · Cited by 382
Protein corona significantly reduces active targeting yield
Mirshafiee, V., Mahmoudi, M., Lou, K., Cheng, J., & Kraft, M. L. (2013) · Chemical Communications · doi:10.1039/c3cc37307j · Cited by 380
Anderson, C. J., & Ferdani, R. (2009) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2009.0674 · Cited by 374
Cadmium-containing nanoparticles: Perspectives on pharmacology and toxicology of quantum dots☆
Rzigalinski, B. A., & Strobl, J. S. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.04.010 · Cited by 345
Torchilin, V. P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.031 · Cited by 332
Cao, Z., & Jiang, S. (2012) · Nano Today · doi:10.1016/j.nantod.2012.08.001 · Cited by 329
Kosmotropes Form the Basis of Protein-Resistant Surfaces
Kane, R. S., Deschatelets, P., & Whitesides, G. M. (2003) · Langmuir · doi:10.1021/la020737x · Cited by 327
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
Choi, H. S., Ipe, B. I., Misra, P., Lee, J. H., Bawendi, M. G., & Frangioni, J. V. (2009) · Nano Letters · doi:10.1021/nl900872r · Cited by 305
Endo- and Exocytosis of Zwitterionic Quantum Dot Nanoparticles by Live HeLa Cells
Jiang, X., Röcker, C., Hafner, M., Brandholt, S., Dörlich, R. M., & Nienhaus, G. U. (2010) · ACS Nano · doi:10.1021/nn101277w · Cited by 299
Susumu, K., Oh, E., Delehanty, J. B., Blanco-Canosa, J. B., Johnson, B. J., Jain, V., Hervey, W. J., Algar, W. R., Boeneman, K., Dawson, P. E., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja201919s · Cited by 293
Studying the mononuclear phagocyte system in the molecular age
Chow, A., Brown, B. D., & Merad, M. (2011) · Nature Reviews Immunology · doi:10.1038/nri3087 · Cited by 279
Zwitteration As an Alternative to PEGylation
Estephan, Z. G., Schlenoff, P. S., & Schlenoff, J. B. (2011) · Langmuir · doi:10.1021/la200227b · Cited by 267
Engineered nanoparticles for biomolecular imaging
Mahmoudi, M., Serpooshan, V., & Laurent, S. (2011) · Nanoscale · doi:10.1039/c1nr10326a · Cited by 262
Engineering Nanocomposite Materials for Cancer Therapy
Minelli, C., Lowe, S. B., & Stevens, M. M. (2010) · Small · doi:10.1002/smll.201000523 · Cited by 255
Engineered Iron-Oxide-Based Nanoparticles as Enhanced T1 Contrast Agents for Efficient Tumor Imaging
Zhou, Z., Wang, L., Chi, X., Bao, J., Yang, L., Zhao, W., Chen, Z., Wang, X., Chen, X., & Gao, J. (2013) · ACS Nano · doi:10.1021/nn305991e · Cited by 249
Small and Stable Sulfobetaine Zwitterionic Quantum Dots for Functional Live-Cell Imaging
Muro, E., Pons, T., Lequeux, N., Fragola, A., Sanson, N., Lenkei, Z., & Dubertret, B. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1005493 · Cited by 247
Compact Zwitterion-Coated Iron Oxide Nanoparticles for Biological Applications
Wei, H., Insin, N., Lee, J., Han, H.-S., Cordero, J. M., Liu, W., & Bawendi, M. G. (2012) · Nano Letters · doi:10.1021/nl202721q · Cited by 245
Yang, W., Zhang, L., Wang, S., White, A. D., & Jiang, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.036 · Cited by 242
Can Controversial Nanotechnology Promise Drug Delivery?
Devadasu, V. R., Bhardwaj, V., & Kumar, M. N. V. R. (2013) · Chemical Reviews · doi:10.1021/cr300047q · Cited by 210
Quantum Dot−Amphipol Nanocomplex for Intracellular Delivery and Real-Time Imaging of siRNA
Qi, L., & Gao, X. (2008) · ACS Nano · doi:10.1021/nn800280r · Cited by 209
Peracchia, M. T., Harnisch, S., Pinto-Alphandary, H., Gulik, A., Dedieu, J. C., Desmaële, D., d’Angelo, J., Müller, R. H., & Couvreur, P. (1999) · Biomaterials · doi:10.1016/s0142-9612(99)00021-6 · Cited by 208
Schlenoff, J. B., Rmaile, A. H., & Bucur, C. B. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802054k · Cited by 205
Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics
Wang, J., Sui, M., & Fan, W. (2010) · Current Drug Metabolism · doi:10.2174/138920010791110827 · Cited by 205
Ultrasmall Rigid Particles as Multimodal Probes for Medical Applications
Lux, F., Mignot, A., Mowat, P., Louis, C., Dufort, S., Bernhard, C., Denat, F., Boschetti, F., Brunet, C., Antoine, R., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201104104 · Cited by 193
Overcoming in vivo barriers to targeted nanodelivery
Chrastina, A., Massey, K. A., & Schnitzer, J. E. (2011) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.143 · Cited by 189
Moghimi, S. M., Hedeman, H., Muir, I. S., Illum, L., & Davis, S. S. (1993) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(93)90105-h · Cited by 176
Effect of Poly(ethylene glycol) Length on the in Vivo Behavior of Coated Quantum Dots
Daou, T. J., Li, L., Reiß, P., Josserand, V., & Texier, I. (2009) · Langmuir · doi:10.1021/la8035083 · Cited by 173
Zwitterion-Stabilized Silica Nanoparticles: Toward Nonstick Nano
Estephan, Z. G., Jaber, J. A., & Schlenoff, J. B. (2010) · Langmuir · doi:10.1021/la103095d · Cited by 172
Emerging role of radiolabeled nanoparticles as an effective diagnostic technique
de Barros, A. L. B., Tsourkas, A., Saboury, B., Cardoso, V. N., & Alavi, A. A. (2012) · EJNMMI Research · doi:10.1186/2191-219x-2-39 · Cited by 169
Zwitterionic Biocompatible Quantum Dots for Wide pH Stability and Weak Nonspecific Binding to Cells
Breus, V. V., Heyes, C. D., Tron, K., & Nienhaus, G. U. (2009) · ACS Nano · doi:10.1021/nn900600w · Cited by 163
Multidentate Zwitterionic Ligands Provide Compact and Highly Biocompatible Quantum Dots
Zhan, N., Palui, G., Safi, M., Ji, X., & Mattoussi, H. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405010v · Cited by 158
Daemen, T., Hofstede, G., ten Kate, M. T., Bakker‐Woudenberg, I. A. J. M., & Scherphof, G. L. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610520 · Cited by 153
Analytical Measurement of PEGylated Molecules
Cheng, T., Chuang, K.-H., Chen, B., & Roffler, S. R. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200478w · Cited by 145
Nanocarriers for Nuclear Imaging and Radiotherapy of Cancer
Mitra, A., Nan, A., Line, B. R., et al. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779026317 · Cited by 130
Bradburne, C. E., Delehanty, J. B., Gemmill, K. B., Mei, B. C., Mattoussi, H. M., Susumu, K., Blanco‐Canosa, J. B., Dawson, P. E., & Medintz, I. L. (2013) · Bioconjugate Chemistry · doi:10.1021/bc4001917 · Cited by 130
Iron oxide magnetic nanoparticles with versatile surface functions based on dopamine anchors
Mazur, M., Barras, A., Kuncser, V., Galatanu, A., Zaitzev, V., Turcheniuk, K., Woisel, P., Lyskawa, J., Laure, W., Siriwardena, A. H., et al. (2013) · Nanoscale · doi:10.1039/c3nr33506b · Cited by 129
Zhang, L., Xue, H., Gao, C., Carr, L. R., Wang, J., Chu, B., & Jiang, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.018 · Cited by 127
Nanoparticles Labeled with Positron Emitting Nuclides: Advantages, Methods, and Applications
Liu, Y., & Welch, M. J. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200264c · Cited by 126
Interaction of Nanoparticles with Immunocompetent Cells: Nanosafety Considerations
Boraschi, D., Costantino, L., & Italiani, P. (2011) · Nanomedicine · doi:10.2217/nnm.11.169 · Cited by 116
Zhou, W., Shao, J., Jin, Q., Wei, Q., Tang, J., & Ji, J. (2010) · Chemical Communications · doi:10.1039/b915125g · Cited by 111
Functions of the Endothelial Cell Surface
Simionescu, M., & Simionescu, N. (1986) · Annual Review of Physiology · doi:10.1146/annurev.ph.48.030186.001431 · Cited by 109
Receptor versus non-receptor mediated clearance of liposomes
Scherphof, G. L., & Kamps, J. A. A. M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00133-6 · Cited by 105
Quarta, A., Curcio, A., Kakwere, H., & Pellegrino, T. (2012) · Nanoscale · doi:10.1039/c2nr30271c · Cited by 97
Preclinical Assessment of a Zwitterionic Tantalum Oxide Nanoparticle X-ray Contrast Agent
Bonitatibus, P. J., Torres, A. S., Kandapallil, B., Lee, B. D., Goddard, G. D., Colborn, R. E., & Marino, M. E. (2012) · ACS Nano · doi:10.1021/nn300928g · Cited by 94
Shedding Light on Tumors Using Nanoparticles
Rao, J. (2008) · ACS Nano · doi:10.1021/nn800669n · Cited by 91
Spatial Charge Configuration Regulates Nanoparticle Transport and Binding Behavior In Vivo
Han, H., Martin, J. D., Lee, J., Harris, D. K., Fukumura, D., Jain, R. K., & Bawendi, M. G. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201208331 · Cited by 91
Increased bone marrow toxicity of doxorubicin bound to nanoparticles
Gibaud, S., Andreux, J. P., Weingarten, C., et al. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90299-2 · Cited by 89
Murthy, A. K., Stover, R. J., Hardin, W. G., Schramm, R., Nie, G. D., Gourisankar, S. P., Truskett, T. M., Sokolov, K., & Johnston, K. P. (2013) · Journal of the American Chemical Society · doi:10.1021/ja400701c · Cited by 85
Liu, X., Huang, H., Jin, Q., & Ji, J. (2011) · Langmuir · doi:10.1021/la2002223 · Cited by 84
The tumor blood vessel as an ideal target for macromolecular anticancer agents
Maeda, H. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90086-7 · Cited by 81
Dong, Z., Mao, J., Yang, M., Wang, D., Bo, S., & Ji, X. (2011) · Langmuir · doi:10.1021/la2038558 · Cited by 75
Novel biocompatible phosphorylcholine-based self-assembled nanoparticles for drug delivery
Salvage, J. P., Rose, S. F., Phillips, G. J., Hanlon, G. W., Lloyd, A. W., Iris, Y., Armes, S. P., Billingham, N. Ć., & Lewis, A. L. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.003 · Cited by 75
Xiao, W., Lin, J., Li, M., Ma, Y., Chen, Y., Zhang, C., Li, D., & Gu, H. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.501 · Cited by 71
Near‐Infrared Emitting Radioactive Gold Nanoparticles with Molecular Pharmacokinetics
Zhou, C., Hao, G., Thomas, P., Liu, J., Yu, M., Sun, S., Öz, O. K., Sun, X., & Zheng, J. (2012) · Angewandte Chemie · doi:10.1002/ange.201203031 · Cited by 53
Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles.
Shokeen, M., Fettig, N., & Rossin, R. (2008) · PubMed · Cited by 52
Compact zwitterion-coated iron oxide nanoparticles for in vitro and in vivo imaging
Wei, H., Bruns†, O. T., Chen, O., & Bawendi, M. G. (2012) · Integrative Biology · doi:10.1039/c2ib20142a · Cited by 48
Linear and hyperbranched phosphorylcholine based homopolymers for blood biocompatibility
Jawanda, M., Lai, B., Kizhakkedathu, J. N., Ishihara, K., & Narain, R. (2013) · Polymer Chemistry · doi:10.1039/c3py00248a · Cited by 27
Sun, X., Yu, S., Wan, J., & Chen, K. (2012) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34343 · Cited by 23
Lu, Y., Chen, W., Chen, W., Stein, A. S., Weiss, L. M., & Huang, Q. (2010) · American Journal of Hematology · doi:10.1002/ajh.21706 · Cited by 23
García, K. P., Zarschler, K., Barreto, J. A., Hesse, J., Spiccia, L., Graham, B., & Stephan, H. (2013) · RSC Advances · doi:10.1039/c3ra43726d · Cited by 22
Self-citationZwitterionic phosphorylcholine-protected water-soluble Ag nanoparticles
Jin, Q., Liu, X., Xu, J., Ji, J., & Shen, J. (2008) · Science China Chemistry · doi:10.1007/s11426-008-0106-4 · Cited by 21
Physiological behavior of quantum dots
Xu, L., & Chen, C. (2012) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1187 · Cited by 9
Cited by
Colloidal nanoparticles as advanced biological sensors
Howes, P. D., Chandrawati, R., & Stevens, M. M. (2014) · Science · doi:10.1126/science.1247390 · Cited by 1,024
Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles
Abadeer, N. S., & Murphy, C. J. (2016) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.5b11232 · Cited by 919
Cancer nanomedicine: A review of recent success in drug delivery
Tran, S., DeGiovanni, P., Piel, B., & Rai, P. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0175-0 · Cited by 879
Li, Q., Wen, C., Yang, J., Zhou, X., Zhu, Y., Zheng, J., Cheng, G., Bai, J., Xu, T., Ji, J., et al. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00344 · Cited by 790
Hildebrandt, N., Spillmann, C. M., Algar, W. R., Pons, T., Stewart, M. H., Oh, E., Susumu, K., Díaz, S. A., Delehanty, J. B., & Medintz, I. L. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00030 · Cited by 730
Metadata
- Authors
- García, K. P., Zarschler, K., Barbaro, L., Barreto, J. A., O'Malley, W., Spiccia, L., Stephan, H., & Graham, B.
- Venue
- Small
- Publisher
- Wiley
- Published
- 2014-03-31
- Volume
- 10
- Issue
- 13
- Pages
- 2516-2529
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W2101332331
- Cited by
- 519
- References
- 120
- FWCI
- 15.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.